SCHEMBL4293515

SCHEMBL4293515

O=C(O)N1CCN[C@H](CCOc2ccc(-n3cccn3)cc2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
GHSR Q92847 1/20 0.40
HDAC4 P56524 1/20 0.38
PARP1 P09874 1/20 0.37
KDM4E B2RXH2 2/20 0.36
MAPK1 P28482 2/20 0.36
REN P00797 3/20 0.36
GPR119 Q8TDV5 1/20 0.36
HRH3 Q9Y5N1 4/20 0.35
GCGR P47871 1/20 0.35
ADRB2 P07550 1/20 0.35
SLC6A4 P31645 1/20 0.34
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4287634 0.99 MEN1 (0.42) MEN1POLBPKMKMT2ANPSR1
SCHEMBL4288516 0.86 CYP19A1 (0.47) PARP1RENGPR119KCNH2CA1
Hydrochloric Acid SCHEMBL4291116 0.85 CYP19A1 (0.46) PARP1RENGPR119KCNH2CA1
Hydrochloric Acid SCHEMBL4288682 0.84 GHSR (0.37) MEN1POLBPKMKMT2ANPSR1
SCHEMBL3493396 0.83 TEAD1 (0.46) MEN1KMT2APARP1KDM4EREN
SCHEMBL4283259 0.82 HDAC4 (0.40) KMT2AHDAC4HRH3
Hydrochloric Acid SCHEMBL4293711 0.81 PARP1 (0.45) MEN1KMT2APARP1KDM4EREN
Hydrochloric Acid SCHEMBL4293709 0.81 PARP1 (0.45) MEN1KMT2APARP1KDM4EREN
Hydrochloric Acid SCHEMBL4283218 0.81 CYP2D6 (0.48) HRH3ADRB2CA1CA2CA9
SCHEMBL4291535 0.81 POLB (0.43) MEN1POLBPKMKMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227560-A1 Substituted imidazole compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227560-A1 Substituted imidazole compound and use thereof REN, ACE, AGT MEN1 1254/4885POLB 3799/4885PKM 847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.